Posts

Showing posts from February, 2025

Unveiling the Role of Biomarkers in Breast Cancer: A Comparative Study on Biological and Molecular Factors

Breast cancer is one of the most complex and heterogeneous diseases, necessitating an in-depth understanding of its biological and molecular factors. The recent study published in the Journal of Biomedical Research & Environmental Sciences (JBRES) titled "Comparative Study of Biomarkers Dependent on Biological, Molecular Factors and Their Clinical Significance in Breast Cancer Treatment" explores the crucial role of biomarkers in improving prognosis, guiding therapeutic decisions, and predicting patient outcomes. Key Highlights of the Study This research provides a comprehensive evaluation of traditional and emerging biomarkers, including: 🔬 Ki-67 Index – A key marker for tumor proliferation, influencing treatment decisions. 🔬 Estrogen (ER) and Progesterone Receptors (PR) – Predictive factors for hormonal therapy efficacy. 🔬 Her2 and cerb-2 Expression – Indicators of aggressive tumor behavior and targeted therapy potential. 🔬 BRCA1 and BRCA2 Genet...

Enhancing Research Visibility: University Library Access with JBRES

In today’s rapidly evolving academic landscape, visibility and accessibility are key factors in determining the impact of research. At the Journal of Biomedical Research & Environmental Sciences (JBRES) , we take pride in ensuring that your research reaches the right audience through university library access . Why University Library Archiving Matters? University libraries serve as essential repositories for scholarly work, offering students, faculty, and researchers access to high-quality, peer-reviewed publications. By archiving articles in multiple university libraries , JBRES ensures that your research is: ✅ Easily Accessible – Available to scholars, educators, and students worldwide. ✅ Cited & Referenced – Academics can utilize your findings in lectures, research papers, and thesis projects. ✅ Permanently Archived – Your work remains part of a global academic database for future generations. ✅ Integrated into Academic Curricula – Institutions use rese...

Bordetella bronchiseptica Infection in an Immunocompetent Adult: A Rare Zoonotic Threat

📢 A recent article “ Bordetella bronchiseptica Infection in an Immunocompetent Adult and a Literature Review on this Rare Zoonosis ” published in the Journal of Biomedical Research & Environmental Sciences (JBRES) highlights a rare case of Bordetella bronchiseptica infection in an immunocompetent adult and provides a comprehensive literature review on this uncommon zoonotic disease. JBRES is currently inviting submissions related to emerging zoonotic infections and their clinical significance. Understanding Bordetella bronchiseptica: An Uncommon Human Pathogen Zoonotic infections continue to pose unique challenges in medical science, particularly when they manifest in unexpected hosts. Bordetella bronchiseptica , a Gram-negative bacterium primarily associated with respiratory infections in animals, has been increasingly recognized as a potential, albeit rare, cause of human infections. While immunocompromised individuals are more susceptible, recent case studies indicate th...

Advancing Hepatitis C Screening: Insights from AST Pesaro-Urbino’s First-Year Results

Hepatitis C Virus (HCV) remains a major public health concern, leading to chronic liver disease and severe complications if left untreated. In 2016, the World Health Organization (WHO) launched a global initiative to eliminate HCV by 2030. As part of this effort, Italy implemented a nationwide screening program, targeting individuals born between 1969 and 1989. A recent study conducted at AST Pesaro-Urbino in the Marche region provides valuable insights into the program’s effectiveness. A recent study titled " Evaluation of Screening Program for Hepatitis C Virus (HCV) At AST Pesaro-Urbino: First Year Results " published in the Journal of Biomedical Research & Environmental Sciences (JBRES). Key Findings from the Study 🔹 Screening Coverage Between August 2023 and July 2024, six blood collection centers screened 6,319 individuals, representing 12.4% of the target population. 🔹 Prevalence of HCV Among those screened, 64 individuals (1%) tested positive for ant...